Literature DB >> 18600433

A high throughput protein formulation platform: case study of salmon calcitonin.

Martinus A H Capelle1, Robert Gurny, Tudor Arvinte.   

Abstract

PURPOSE: The feasibility of using high throughput spectroscopy for characterization and selection of physically stable protein formulations was studied.
MATERIALS AND METHODS: A hundred aqueous formulations of salmon calcitonin (sCT) were prepared using 20 buffer compositions. The solutions had pH values between 2.5 and 10.5. The stability of the sCT formulations was analyzed over 1 week by the following assays: (1) protein concentration, (2) volume control by measuring pathlength, (3) turbidity (absorbance at 350 nm), (4) intrinsic tyrosine fluorescence, (5) 1-anilino-naphthalene-8-sulfonate (ANS) fluorescence, (6) Nile Red fluorescence. Addition of the dyes (Nile Red and ANS) was used to study protein conformational changes.
RESULTS: After 1 day, 27 out of the 100 formulations of salmon calcitonin were stable. After 7 days, 12 stable sCT formulations remained. The best salmon calcitonin formulation was in 10 mM sodium acetate buffer with pH values between 3.5 and 5.5.
CONCLUSIONS: The findings are in accordance with the sCT formulations that were patented and used commercially. This can be considered as a proof of concept for the high throughput protein formulation platform.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600433     DOI: 10.1007/s11095-008-9662-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Evaluation of liquid handling conditions in microplates.

Authors:  M Berg; K Undisz; R Thiericke; P Zimmermann; T Moore; C Posten
Journal:  J Biomol Screen       Date:  2001-02

2.  Induction and analysis of aggregates in a liquid IgG1-antibody formulation.

Authors:  Hanns-Christian Mahler; Robert Müller; Wolfgang Friess; Aurelie Delille; Susanne Matheus
Journal:  Eur J Pharm Biopharm       Date:  2005-04       Impact factor: 5.571

3.  Detection and characterization of protein aggregates by fluorescence microscopy.

Authors:  Barthélemy Demeule; Robert Gurny; Tudor Arvinte
Journal:  Int J Pharm       Date:  2006-08-26       Impact factor: 5.875

4.  The structure and mechanism of formation of human calcitonin fibrils.

Authors:  T Arvinte; A Cudd; A F Drake
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

5.  A turbidimetric method to determine visual appearance of protein solutions.

Authors:  B M Eckhardt; J Q Oeswein; D A Yeung; T D Milby; T A Bewley
Journal:  J Pharm Sci Technol       Date:  1994 Mar-Apr

6.  1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation.

Authors:  D Matulis; R Lovrien
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

7.  8-anilino-1-naphthalene sulfonic acid (ANS) induces folding of acid unfolded cytochrome c to molten globule state as a result of electrostatic interactions.

Authors:  V Ali; K Prakash; S Kulkarni; A Ahmad; K P Madhusudan; V Bhakuni
Journal:  Biochemistry       Date:  1999-10-12       Impact factor: 3.162

Review 8.  Calcitonin therapy in osteoporosis.

Authors:  Manuel Muñoz-Torres; Guillermo Alonso; Mezquita Pedro Raya
Journal:  Treat Endocrinol       Date:  2004

9.  Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.

Authors:  T Arvinte; A F Drake
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

10.  Enhanced potency of human calcitonin when fibrillation is avoided.

Authors:  A Cudd; T Arvinte; R E Das; C Chinni; I MacIntyre
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

View more
  4 in total

Review 1.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

2.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

3.  Fluorescent molecular rotors as dyes to characterize polysorbate-containing IgG formulations.

Authors:  Andrea Hawe; Vasco Filipe; Wim Jiskoot
Journal:  Pharm Res       Date:  2009-12-30       Impact factor: 4.200

4.  Comparative Effects of Metal-Catalyzed Oxidizing Systems on Carbonylation and Integrity of Therapeutic Proteins.

Authors:  Dmitry Kryndushkin; V Ashutosh Rao
Journal:  Pharm Res       Date:  2015-10-23       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.